News

Half a billion for the liver

The Russian Ministry of Defense has announced a competition for the implementation of experimental design work on the creation of a bioengineered liver. The maximum contract price is 518.5 million rubles.

Collective Use Centers of the First MGMU

There are 3 centers for collective use at the university: "Transfusion Medicine", "Pharmaceutical" and "Regenerative Medicine".

Rusnano will profitably sell Ruskhimbio

The Board of Directors approved Rusnano's withdrawal from the previously invested infrastructure project to create a Russian warehouse catalog of chemical and biochemical reagents (Ruskhimbio LLC).

The winners of the state prizes of the Russian Federation in the field of science and technology are named

For the first time in history, this award in all nominations related to academic science was received by specialists whose work results have found practical application.

Stem Cells: China's 101st Latest Warning

The ban on stem cell treatment and clinical research in this direction is due to the intention of the Chinese government to take cell therapy under state control.

How do you like the work of doctors?

About 15,000 patients rated the work of doctors on a 10-point scale. The average score was 9.28 points. The maximum possible 10 points were given to their doctors by 70.1% of respondents, 0-1 points – less than 2%.

The new status will help the development of the pharmaceutical cluster

The government of St. Petersburg plans to obtain the status of an innovation region for the further development of the pharmaceutical cluster.

With a slight movement, fibroblasts turn into elegant nerve cells

In less than a week, about 20% of fibroblasts turned into neurons capable of performing all the functions of "ordinary" ones: expressing specific proteins, generating action potential, forming synapses.

"Female Viagra" – on sale soon!

The drug Flibanserin (Flibanserin) was developed as an antidepressant, but it turned out to be ineffective in this capacity. But he had an unintended effect: an increase in sexual desire and the brightness of sexual sensations in women.

Chromosome-2009: a large symposium and an unusual photo exhibition

On September 1, the International Conference "Chromosome-2009" opened in Novosibirsk.

Eye of the tooth

Initially, doctors turned the tooth into a "stand" for special optical lenses. Then the tooth was returned to its place and within three months it overgrown with new tissues and "reunited" with blood vessels. And finally, the whole structure was carefully inserted into the patient's eyeball. After two weeks, the vision in the eye was almost completely restored.

Competition "Peptide drugs – drugs of the XXI century": interim results

Within the framework of the II International Competition of Young Scientists "Peptide drugs – drugs of the XXI century", 8 grants were awarded for conducting clinical trials and 2 grants for supporting research projects.

New Aging Marker Determines Biological Age by Blood test

The study showed a clear relationship between the level of cyclin-dependent kinase inhibitor in the blood and other biochemical markers of aging, as well as indicators such as age, physical activity and tobacco use.

Are you planning a start-up? Learn to survive!

In the information and consulting center "Innovation" you can take part in the training program "Start-up: instructions for survival" for free.

Progress in the field of artificial biomaterials

The new synthetic biomaterial, which is a strong network of DNA strands and nanotubes, resembles soft tissues of biological origin in mechanical properties.

Gene therapy of viral keratitis

Chinese researchers have developed a way to treat keratitis caused by the herpes virus, based on the destruction of the virus genome.

A clone of a Tibetan pig

The Tibetan pig, which lives in the Qinghai-Tibetan Highlands, is a rare species of pig, can inhabit highlands, cold and mountainous areas.

Yescarta made in Cina

Shanghai-based company Fosun Kite Biotechnology, a joint venture between China and the United States, will produce the drug Yescarta.

Bacteriophages will help antibiotics

The combination of antibiotics with therapy with bacteriophage viruses, which do not kill, but only weaken pathogenic bacteria, can significantly alleviate the fate of many patients in the future.

The herpes virus will help in the creation of antiviral vaccines